Navigation Links
"From Survive to Thrive" campaign seeks to enhance access to lifesaving donor milk in Neonatal Intensive Care Units in 2014

PHILADELPHIA, Nov. 22, 2013 /PRNewswire-iReach/ -- A forthcoming campaign to enhance access to human milk for premature infants in hospital settings was announced today by Elena Medo, Chair and CEO of Medolac Laboratories during a plenary presentation at the Annual International Meeting of the Academy of Breastfeeding Medicine.  

The Campaign sets an ambitious target to improve access to human milk in Neonatal Intensive Care Units from less than 5% today to 20% by the end of 2014.  "Nothing holds a greater opportunity to improve health outcomes for premature infants than the accessibility of safe, affordable and reliable supply of human milk adapted for their use".

The shortage of human milk in Neonatal Intensive Care Units has been well documented, including in an article published by Ms. Medo in the Journal of Breastfeeding Medicine (Vol. 8, No.5) earlier this month, highlighting the critical shortage of donor milk for very low birth weight (VLBW) infants despite the clear health advantages it brings, particularly by greatly reducing the incidence of gastrointestinal diseases such as sepsis and necrotizing enterocolitis. 

Achievement of this ambitious target will be met by greatly increasing the supply of donor milk through the development of cooperative milk banking.  Elena Medo has been a pioneer of the innovative coop model as a way to give donors a voice, fair compensation for their milk and provide incentive to donors to improve supply. 

Donor milk safety is also a key component of increasing access, since premature infants are often immunocompromised and experience a high risk of infection.  Medolac Laboratories requires blood screening of donor candidates, testing of each donor's milk for disease, contamination and drugs of abuse, testing of pooled donor milk for safety and nutrition as well as the testing of finished product. 
More information about the "From Survive to Thrive" campaign will be made available as Medolac makes progress towards fulfilling its objective in 2014.   

About Medolac:

Our vision is to provide human milk based therapies to critically ill babies and children on a global basis by applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk while providing the safest, highest quality human milk formulations available to babies in need.    Medolac Laboratories is a Delaware registered, public benefit corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. 

Media Contact: Yvonne Arroyo, Medolac Laboratories, 8665997740,

News distributed by PR Newswire iReach:

SOURCE Medolac Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. What Hospitals Must Do to Thrive -- Not Just Survive -- on Medicare Margins
2. Medtech companies urged to evolve business model to survive
3. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
4. UV Flu Technologies to Commence a National TV Advertising Campaign
5. Research Triangle Region Debuts Talent Attraction Campaign at BIO 2012
6. Mandy Moore Campaigns for Clean Water, GreenBeanBuddy Encourages Mothers to Help Through the Use of Green Cleaning Products
7. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
8. Adult Stem Cell Therapy Breakthrough Leads to Crowd Funding Campaign on for Centagen, Inc.
9. Medbox, Inc. Initiates "Responsible Consumption" Campaign for Marijuana in Recreational States
10. Texas Fertility Center ‘March Dadness’ Campaign Focuses on the Odds of Beating Male Infertility
11. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
Post Your Comments:
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
(Date:11/24/2015)... ... , ... The Academy of Model Aeronautics (AMA), led by its Executive Council, ... Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing has ... type of racing and several new model aviation pilots have joined the community because ...
(Date:11/24/2015)... York , November 24, 2015 ... a recent market research report released by Transparency Market ... to expand at a CAGR of 17.5% during the ... Prenatal Testing Market - Global Industry Analysis, Size, Volume, ... the global non-invasive prenatal testing market to reach a ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... today that the remaining 11,000 post-share consolidation (or ... Warrants (the "Series B Warrants") subject to the ... on November 23, 2015, which will result in ... giving effect to the issuance of such shares, ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th ... Paris from 17 th until 19 th ... leader, has invented the first combined scanner in the world ... scanning surface. Until now two different scanners were required: one ... both on the same surface. This innovation is an ...
(Date:11/16/2015)... JOSE, Calif. , Nov 16, 2015 /PRNewswire/ ... developer of human interface solutions, today announced expansion ... Synaptics TouchView ™ touch controller and display ... architectural revolution of smartphones. These new TDDI products ... include TD4100 (HD resolution), TD4302 (WQHD resolution), and ...
(Date:11/11/2015)... MINNETONKA, Minn. , Nov. 11, 2015   MedNet ... the entire spectrum of clinical research, is pleased to announce ... Partnerships in Clinical Trials (PCT) event, to be held ... will be able to view live demonstrations of ... platform, and learn how iMedNet has been able ...
Breaking Biology News(10 mins):